Clinical Exome Sequencing as a Novel Tool for Diagnosing Loeys-Dietz Syndrome Type 3

Eur J Vasc Endovasc Surg. 2015 Dec;50(6):816-21. doi: 10.1016/j.ejvs.2015.08.003. Epub 2015 Sep 26.

Abstract

Objective/background: In rare genetic vascular syndromes the diagnosis may not be apparent from the phenotype, but might be important for proper management.

Methods: A previously healthy woman without dysmorphic features presented with pregnancy associated vascular dissections and aneurysms. Next generation clinical exome sequencing was performed.

Results: The differential diagnosis of spontaneous arterial dissection is outlined. The patient's diagnosis became evident after clinical exome sequencing detected a novel missense mutation in the evolutionary conserved region of SMAD3, confirming the diagnosis of Loeys-Dietz syndrome (LDS) type 3. A brief overview of the various types of LDS and their management is presented.

Conclusion: Clinical exome sequencing proved useful in diagnosing LDS type 3 where detailed vascular surveillance and timely intervention with a low threshold is recommended.

Keywords: Aneurysm; Clinical exome sequencing; Loeys-Dietz syndrome; Pregnancy; Spontaneous arterial dissection.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Coronary Angiography
  • DNA Mutational Analysis*
  • Diagnosis, Differential
  • Exome*
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing / methods*
  • Humans
  • Loeys-Dietz Syndrome / complications
  • Loeys-Dietz Syndrome / diagnosis*
  • Loeys-Dietz Syndrome / genetics*
  • Loeys-Dietz Syndrome / therapy
  • Magnetic Resonance Angiography
  • Mutation, Missense*
  • Phenotype
  • Predictive Value of Tests
  • Pregnancy
  • Prognosis
  • Smad3 Protein / genetics*

Substances

  • SMAD3 protein, human
  • Smad3 Protein